Global $10 Billion Probiotics Dietary Supplement Market 2017-2022 – Key Players are DowDuPont, Chr. Hansen Holding A/S, Royal DSM N.V., Cargill. Lifeway Foods, and Kibow Biotech
The “Probiotics Dietary Supplement Market – Forecasts from 2017 to 2022” report has been added to Research and Markets’ offering. Probiotics dietary supplement market is projected to witness a CAGR of 8.09% during the forecast period to reach a total market size of US$10.225 billion by 2022, increasing from US$6.928 billion in 2017 Shifting people […]
Kibow® Biotech’s “Enteric Dialysis®” Technology and Its Renadyl™ Product Formulation for Maintaining Healthy Kidney Function Is to Showcase Its Ultimate Validation at the Annual ASN 2017 – Kidney Week Conference.
Kibow® Biotech is proud to announce its twentieth year of operations as a leader in the kidney health supplement marketplace. For the past 13 years, Kibow® has been participating and exhibiting at the annual meeting of the American Society of Nephrology: Kidney Week event (https://www.asn-online.org/kidneyweek/) educating nephrology professionals on the crucial role of the gut-kidney […]
Revolutionary, Non-Invasive, Cost Effective Renal Technology Working 24/7 Shows It Helps Maintain Healthy Kidney Function
For 20 years, Kibow® Biotech has been refining a novel approach to maintaining healthy kidney function “Enteric Dialysis®”. Enteric Dialysis® utilizes probiotics (yes, probiotics) to metabolize the waste products (toxins) building up in the bloodstream due to reduced kidney function. Kibow® Biotech will be exhibiting for the 13th consecutive year at the annual American Society […]
Kibow® Biotech Celebrates 20 Years of Operations With Further Validation of Its “Enteric Dialysis®” Technology, and Renadyl™ Product Formulation for Maintaining Healthy Kidney Function
Kibow® Biotech is proud to announce its twentieth year of operations as a leader in the kidney health supplement marketplace. Nine out of 10 biotech companies fail within the first five years of business; Kibow® has managed to stay on the cutting edge of science with its product Renadyl™ based on “Enteric Dialysis®” technology. Renadyl™ […]
Kibow® Biotech Inc. (Buzz of Bio Winner, 2014) Receives US Patent for Gout/Hyperuricemia Product Formulation Based on Modulation of the Gut Microbiome With Probiotics and Prebiotics
Kibow® Biotech Inc., a pioneer in developing “Enteric Dialysis®” technology, is pleased to announce the issuance of a new patent covering a unique method for preventing or treating gout or hyperuricemia by the U.S. Patent and Trademark Office on May 23rd 2017.